(Q37781669)

23 August 2017

title

Current insights into ocular graft-versus-host disease (English)

1 reference

23 August 2017

Anjo Riemens

1

1 reference

23 August 2017

Liane te Boome

2

1 reference

23 August 2017

Saskia Imhof

3

1 reference

23 August 2017

Jürgen Kuball

4

1 reference

23 August 2017

Aniki Rothova

5

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20729735

20 June 2024

publication date

1 November 2010

1 reference

full work available at URL

23 August 2017

https://journals.lww.com/10.1097/ICU.0b013e32833eab64

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Current Opinion in Ophthalmology

20 June 2024

published in

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

6

1 reference

23 August 2017

page(s)

485-494

1 reference

Chronic ocular surface disease after allogeneic bone marrow transplantation.

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Graft-versus-host disease

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD.

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Recognizing and managing chronic graft-versus-host disease

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ancillary and supportive care in chronic graft-versus-host disease

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Diagnosis and manifestations of chronic graft-versus-host disease

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Marrow transplantation from related donors other than HLA-identical siblings

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Immunobiology of allogeneic hematopoietic stem cell transplantation

20 June 2024

11

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Graft-versus-host disease

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Pathophysiology of graft-versus-host disease

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Role of adhesion molecules in activation signaling in T lymphocytes

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The role of B cells in the pathogenesis of graft-versus-host disease

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Approaches to graft-vs-host disease

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Novel approaches to the therapy of steroid-resistant acute graft-versus-host disease

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Risk assessment in haematopoietic stem cell transplantation: GvHD prevention and treatment

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Imatinib for refractory chronic graft-versus-host disease with fibrotic features.

20 June 2024

23

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ocular graft-versus-host disease after allogeneic stem cell transplantation

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ocular Manifestation of Acute Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ocular findings after allogeneic hematopoietic stem cell transplantation

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ocular Manifestations of Graft-vs-Host Disease

20 June 2024

28

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The eye in bone marrow transplantation. I. Clinical study

20 June 2024

29

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The eye in bone marrow transplantation. II. Histopathology

20 June 2024

30

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease

20 June 2024

31

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ocular complications in high-dose chemoradiotherapy and marrow transplantation

20 June 2024

32

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Extended-wear silicone hydrogel soft contact lenses in the management of moderate to severe dry eye signs and symptoms secondary to graft-versus-host disease

20 June 2024

33

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease

20 June 2024

34

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Cell populations and adhesion molecules expression in conjunctiva before and after bone marrow transplantation

20 June 2024

36

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Retinal complications of bone marrow and solid organ transplantation

20 June 2024

37

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Update on ocular graft versus host disease

20 June 2024

38

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The eye in bone marrow transplantation. VI. Retinal complications

20 June 2024

39

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Anterior uveitis: a manifestation of graft-versus-host disease

20 June 2024

40

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Bilateral uveitis manifesting as a complication of chronic graft-versus-host disease after allogeneic bone marrow transplantation

20 June 2024

41

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Topical corticosteroid therapy for cicatricial conjunctivitis associated with chronic graft-versus-host disease

20 June 2024

42

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Efficacy of different dry eye treatments with artificial tears or ocular lubricants: a systematic review

20 June 2024

43

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

20 June 2024

44

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca

20 June 2024

45

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Epidermal growth factor is a constant component of normal human tear fluid

20 June 2024

46

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease

20 June 2024

47

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years

20 June 2024

48

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group

20 June 2024

49

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group

20 June 2024

50

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

The use of topical cyclosporin A in ocular graft-versus-host-disease

20 June 2024

51

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Ophthalmic cyclosporine use in ocular GVHD

20 June 2024

52

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease

20 June 2024

53

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics

20 June 2024

54

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids

20 June 2024

55

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Topical 0.03% tacrolimus ointment in the management of ocular surface inflammation in chronic GVHD.

20 June 2024

56

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Topical tranilast for treatment of the early stage of mild dry eye associated with chronic GVHD.

20 June 2024

57

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

Does orally administered doxycycline reach the tear film?

20 June 2024

58

1 reference

https://api.crossref.org/works/10.1097/ICU.0B013E32833EAB64

20 June 2024

Identifiers

1 reference

23 August 2017

1 reference